Aberrant Cholesterol Metabolism in Colorectal Cancer Represents a Targetable Vulnerability
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Gradient boosting reveals spatially diverse cholesterol gene signatures in colon cancer.
Yang X, Chatterjee D, Couetil J, Liu Z, Ardon V, Chen C Front Genet. 2024; 15:1410353.
PMID: 39678375 PMC: 11638177. DOI: 10.3389/fgene.2024.1410353.
Squalene Epoxidase: Its Regulations and Links with Cancers.
Zhang L, Cao Z, Hong Y, He H, Chen L, Yu Z Int J Mol Sci. 2024; 25(7).
PMID: 38612682 PMC: 11011400. DOI: 10.3390/ijms25073874.
References
1.
Gao S, Soares F, Wang S, Wong C, Chen H, Yang Z
. CRISPR screens identify cholesterol biosynthesis as a therapeutic target on stemness and drug resistance of colon cancer. Oncogene. 2021; 40(48):6601-6613.
PMC: 8639446.
DOI: 10.1038/s41388-021-01882-7.
View
2.
Siegel R, Miller K, Fuchs H, Jemal A
. Cancer statistics, 2022. CA Cancer J Clin. 2022; 72(1):7-33.
DOI: 10.3322/caac.21708.
View
3.
Li J, Gu D, Lee S, Song B, Bandyopadhyay S, Chen S
. Abrogating cholesterol esterification suppresses growth and metastasis of pancreatic cancer. Oncogene. 2016; 35(50):6378-6388.
PMC: 5093084.
DOI: 10.1038/onc.2016.168.
View
4.
Cerami E, Gao J, Dogrusoz U, Gross B, Sumer S, Aksoy B
. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012; 2(5):401-4.
PMC: 3956037.
DOI: 10.1158/2159-8290.CD-12-0095.
View
5.
Fece de la Cruz F, Gapp B, Nijman S
. Synthetic lethal vulnerabilities of cancer. Annu Rev Pharmacol Toxicol. 2014; 55:513-31.
DOI: 10.1146/annurev-pharmtox-010814-124511.
View